[go: up one dir, main page]

WO2009007622A3 - Composition dermatologique comprenant des vésicules lipidiques de calcitriol, son procédé de préparation et son utilisation - Google Patents

Composition dermatologique comprenant des vésicules lipidiques de calcitriol, son procédé de préparation et son utilisation Download PDF

Info

Publication number
WO2009007622A3
WO2009007622A3 PCT/FR2008/051193 FR2008051193W WO2009007622A3 WO 2009007622 A3 WO2009007622 A3 WO 2009007622A3 FR 2008051193 W FR2008051193 W FR 2008051193W WO 2009007622 A3 WO2009007622 A3 WO 2009007622A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition containing
dermatological composition
preparing same
lipidic vesicles
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/051193
Other languages
English (en)
Other versions
WO2009007622A2 (fr
Inventor
Lara Baudonnet
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to EP08806120A priority Critical patent/EP2173326A2/fr
Priority to CA002691398A priority patent/CA2691398A1/fr
Publication of WO2009007622A2 publication Critical patent/WO2009007622A2/fr
Publication of WO2009007622A3 publication Critical patent/WO2009007622A3/fr
Priority to US12/647,021 priority patent/US20100221350A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à des compositions comprenant des vésicules lipidiques dispersées dans une phase hydrophile, lesdites vésicules comprenant au moins un dérivé de la vitamine D, et particulièrement le calcitriol; à leur utilisation dans le traitement de pathologies dermatologiques, et à leur procédé de préparation.
PCT/FR2008/051193 2007-06-29 2008-06-27 Composition dermatologique comprenant des vésicules lipidiques de calcitriol, son procédé de préparation et son utilisation Ceased WO2009007622A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08806120A EP2173326A2 (fr) 2007-06-29 2008-06-27 Composition dermatologique comprenant des vésicules lipidiques de calcitriol, son procédé de préparation et son utilisation
CA002691398A CA2691398A1 (fr) 2007-06-29 2008-06-27 Composition dermatologique comprenant des vesicules lipidiques de calcitriol, son procede de preparation et son utilisation
US12/647,021 US20100221350A1 (en) 2007-06-29 2009-12-24 Dermatological compositions comprising vitamin d lipid vesicles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756165A FR2917976B1 (fr) 2007-06-29 2007-06-29 Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
FR0756165 2007-06-29

Publications (2)

Publication Number Publication Date
WO2009007622A2 WO2009007622A2 (fr) 2009-01-15
WO2009007622A3 true WO2009007622A3 (fr) 2009-05-22

Family

ID=38957738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051193 Ceased WO2009007622A2 (fr) 2007-06-29 2008-06-27 Composition dermatologique comprenant des vésicules lipidiques de calcitriol, son procédé de préparation et son utilisation

Country Status (5)

Country Link
US (1) US20100221350A1 (fr)
EP (1) EP2173326A2 (fr)
CA (1) CA2691398A1 (fr)
FR (1) FR2917976B1 (fr)
WO (1) WO2009007622A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2942050T1 (sl) * 2014-05-06 2023-01-31 S.I.I.T. s.r.l. - SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI Razpršljiva oljnata sestava, osnovana na lipotopnih vitaminih skupine D, in uporaba le-teh
FR3041541B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
CN112630257B (zh) * 2020-12-28 2024-03-22 宁波铭瑞中兴电子科技有限公司 一种玻璃水水箱监控方法、系统、智能终端以及存储介质

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
WO1997037637A1 (fr) * 1996-04-04 1997-10-16 Ortho Pharmaceutical Corporation Formulation topique de vitamine d a base de liposomes
US6004580A (en) * 1994-05-24 1999-12-21 Leiras Oy Pharmaceutical compositions derived from microemulsion-based gels
WO2000054838A1 (fr) * 1999-03-16 2000-09-21 Nycomed Pharma As Composition contenant du calcium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
FR2735658B1 (fr) * 1995-06-21 1997-09-12 Capsulis Encapsulation de composes a usage alimentaire par des tensioactifs
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
AU2001270554A1 (en) * 2000-06-06 2001-12-17 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US6004580A (en) * 1994-05-24 1999-12-21 Leiras Oy Pharmaceutical compositions derived from microemulsion-based gels
WO1997037637A1 (fr) * 1996-04-04 1997-10-16 Ortho Pharmaceutical Corporation Formulation topique de vitamine d a base de liposomes
WO2000054838A1 (fr) * 1999-03-16 2000-09-21 Nycomed Pharma As Composition contenant du calcium

Also Published As

Publication number Publication date
US20100221350A1 (en) 2010-09-02
FR2917976A1 (fr) 2009-01-02
FR2917976B1 (fr) 2010-05-28
EP2173326A2 (fr) 2010-04-14
CA2691398A1 (fr) 2009-01-15
WO2009007622A2 (fr) 2009-01-15

Similar Documents

Publication Publication Date Title
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2010037059A3 (fr) Antagonistes hétéroaryliques des récepteurs de prostaglandine d<sb>2</sb>
PT2344198T (pt) Preparações farmacêuticas à base de lípidos para aplicação tópica
WO2010013224A3 (fr) Nanoparticules de curcumine et leurs procédés de production
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2010072958A3 (fr) Composition pharmaceutique topique comprenant un principe actif sensible a l'eau
WO2009108720A3 (fr) Antagonistes des récepteurs d2 de la prostaglandine
WO2007146965A3 (fr) Composés destinés au traitement d'une maladie périodontale
WO2008063808A3 (fr) Nanostructures amphiphiles peptidiques encapsulées
WO2010021607A3 (fr) Préparation pharmaceutique
WO2009090237A3 (fr) Dérivés fongicides d'hydroximoyl-tétrazoles
WO2007109279A3 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
WO2010121164A3 (fr) Composés de 1,4-benzodiazépinone et leur utilisation dans le traitement du cancer
WO2008011272A3 (fr) Compositions antioxydantes liquides monophasiques liposolubles et leurs procédés de fabrication
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
WO2007044950A3 (fr) Formes cristallines de docetaxel et leurs processus de preparation
WO2009084034A3 (fr) Dérivés de chromane utilisés comme modulateurs de trpv3
SI2231598T1 (sl) Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki
WO2009051417A3 (fr) Dérivés de lactame phénanthrène présentant une activité anticancéreuse et procédé de préparation de ceux-ci
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
MX2009003060A (es) Emulsion.
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08806120

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008806120

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2691398

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE